GLNYSELife InsuranceFiscal year ends December 31Also trades as GL.PD
GLOBE LIFE INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$167.85−0.92 (-0.55%)
Close on Oct 19, 2026
- Market cap
- $13.24B
- P/E (TTM)
- 11.1
- Dividend yield
- 0.64%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
–
Operating margin
–
Net margin
19.4%+3.9 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +3.7% | +4.7% | +4.8% | +4.8% | |
| Net income | +8.4% | +9.1% | +9.7% | +8.2% | |
| EPS, diluted | +17.8% | +15.9% | +15.6% | +13.0% | |
| Free cash flow | -5.8% | -3.5% | -2.7% | +1.5% | |
| Dividend per share | +12.5% | +9.2% | +7.6% | +7.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 12.8% | 9.1% | 20.6% | |
| Return on assets | 2.7% | 2.7% | 3.9% | |
| Debt to equity | 0.31 | 0.22 | 0.44 | |
| Interest coverage | 9.4× | 10.4× | – | |
| Capex to revenue | 0.6% | 0.9% | 2.4% | |
| Diluted shares | 122M | 107M | 83M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Globe Life generated $7.14B from operations and spent $4.14B on capital expenditure, dividends and share buybacks. 8% of that went back into the business.
Generated
$7.14B
Used
$4.14B
Capital expenditure$329.26M8%Dividends$416.26M10%Share buybacks$3.39B82%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin19.4%
×Asset turnover0.20×
×Equity multiplier5.31×
=Return on equity, FY202520.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 19.4% | 0.20× | 5.31× | 20.6% |
| FY2024 | 18.5% | 0.20× | 5.83× | 21.9% |
| FY2023 | 17.8% | 0.20× | 6.41× | 23.0% |
| FY2022 | 17.1% | 0.19× | 9.37× | 30.0% |
| FY2021 | 20.2% | 0.17× | 5.46× | 19.1% |
| FY2020 | 15.4% | 0.17× | 3.43× | 9.1% |
| FY2019 | 16.8% | 0.18× | 3.86× | 12.0% |
| FY2018 | 16.3% | 0.18× | 4.00× | 12.0% |
| FY2017 | 35.0% | 0.19× | 4.16× | 26.9% |
| FY2016 | 14.0% | 0.19× | 4.79× | 12.8% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
7of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.16B
- Cash generatingOperating cash flow above zero$1.40B
- Return on assets improvedROA up on the prior year3.8% → 4.0%
- Earnings backed by cashOperating cash flow above net income$1.40B vs $1.16B
- Less leverageLong-term debt to assets fell8.0% → 7.5%
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise90M → 83M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.21 → 0.21